Kaye Scholer Reps Novartis In $420M Elidel Sale
Novartis AG said Thursday it would sell its skin cream treatment Elidel to Swedish pharmaceutical company Meda AB for $420 million in cash as part of its plan to focus on...To view the full article, register now.
Already a subscriber? Click here to view full article